Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Common Equity (2016 - 2025)

Historic Common Equity for Medifast (MED) over the last 16 years, with Q4 2025 value amounting to $198.9 million.

  • Medifast's Common Equity fell 532.53% to $198.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $198.9 million, marking a year-over-year decrease of 532.53%. This contributed to the annual value of $198.9 million for FY2025, which is 532.53% down from last year.
  • According to the latest figures from Q4 2025, Medifast's Common Equity is $198.9 million, which was down 532.53% from $214.7 million recorded in Q3 2025.
  • In the past 5 years, Medifast's Common Equity registered a high of $216.0 million during Q1 2022, and its lowest value of $129.5 million during Q2 2022.
  • For the 5-year period, Medifast's Common Equity averaged around $192.2 million, with its median value being $200.2 million (2023).
  • Per our database at Business Quant, Medifast's Common Equity surged by 6677.72% in 2021 and then crashed by 3349.6% in 2022.
  • Over the past 5 years, Medifast's Common Equity (Quarter) stood at $202.5 million in 2021, then fell by 23.43% to $155.0 million in 2022, then grew by 29.95% to $201.5 million in 2023, then rose by 4.28% to $210.1 million in 2024, then fell by 5.33% to $198.9 million in 2025.
  • Its last three reported values are $198.9 million in Q4 2025, $214.7 million for Q3 2025, and $216.0 million during Q2 2025.